Baby Formula and NEC Litigation
General educational information — not legal advice.
Overview of Baby Formula Litigation
Baby formula litigation in the United States has primarily focused on claims that cow milk-based preterm infant formula products — specifically Enfamil (manufactured by Mead Johnson/Reckitt) and Similac (manufactured by Abbott Laboratories) — caused necrotising enterocolitis (NEC) in premature infants. NEC is a devastating gastrointestinal disease that primarily affects premature newborns.
What Is Necrotising Enterocolitis (NEC)?
Necrotising enterocolitis is a serious gastrointestinal condition in which tissue in the small or large intestine becomes inflamed and begins to die. It primarily affects premature infants, particularly those born before 32 weeks of gestation. NEC can cause severe complications including intestinal perforation, sepsis, and death. Survivors may face long-term health challenges including short bowel syndrome and developmental delays.
The Alleged Link Between Cow Milk Formula and NEC
Scientific research has suggested that premature infants fed cow milk-based formula or fortifiers may have a higher risk of developing NEC compared to those fed human breast milk. Studies published in peer-reviewed journals have found statistically significant associations between cow milk-based products and NEC in premature infants. Plaintiffs allege that manufacturers knew about this research and failed to adequately warn healthcare providers and parents.
Allegations Against Manufacturers
Lawsuits filed against Mead Johnson and Abbott Laboratories allege that these companies knew or should have known that their cow milk-based preterm infant formula products posed a risk of NEC in premature infants, and that they failed to include adequate warnings on their products or in their marketing materials directed at neonatal intensive care units (NICUs) and healthcare providers.
Multidistrict Litigation
Baby formula NEC cases have been consolidated into a federal multidistrict litigation (MDL) in the Northern District of Illinois. The MDL allows for coordinated pretrial proceedings. Bellwether trials are expected to provide important guidance on how courts and juries evaluate the scientific evidence and the manufacturers liability.
Who May Be Affected
Families of premature infants who were fed cow milk-based formula or fortifiers in a NICU setting and subsequently developed NEC may be among those with potential claims. The litigation primarily involves infants born prematurely (typically before 32 weeks gestation) who were hospitalised in NICUs and fed these specific products.
The Role of Human Breast Milk
Medical organisations including the American Academy of Pediatrics have long recommended human breast milk as the preferred nutrition for premature infants, in part because of its protective effects against NEC. The litigation has brought renewed attention to hospital feeding practices and the promotion of formula products in NICU settings.
Current Litigation Status
Baby formula NEC litigation is active and ongoing. The MDL is in pretrial proceedings, and the outcomes of bellwether trials will be closely watched. The litigation involves complex scientific and medical evidence, and outcomes remain uncertain. Families who believe their premature infant developed NEC after being fed cow milk-based formula should seek independent legal advice.
Want to Learn More?
Browse all litigation topics or request general educational information tailored to your situation.